An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis - Johns Hopkins University Center for Tuberculosis Research

An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis

Front Immunol. 2022 Sep 16;13:972266. doi: 10.3389/fimmu.2022.972266. eCollection 2022. Styliani Karanika 1 2, James T Gordy 3, Pranita Neupane 1 2, Theodoros Karantanos 4, Jennie ...